Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
7
88%
Ph phase_4
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
7(87.5%)
Phase 4Post-market surveillance
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting4
Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 37 (87.5%)
Phase 41 (12.5%)

Trials by Status

completed338%
not_yet_recruiting450%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8